GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » PURE Bioscience Inc (OTCPK:PURE) » Definitions » YoY EBITDA Growth

PURE Bioscience (PURE Bioscience) YoY EBITDA Growth : 11.11% (As of Jan. 2024)


View and export this data going back to 1996. Start your Free Trial

What is PURE Bioscience YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PURE Bioscience's YoY EBITDA Growth for the quarter that ended in Jan. 2024 was 11.11%.

PURE Bioscience's EBITDA per Share for the three months ended in Jan. 2024 was $-0.01.

PURE Bioscience YoY EBITDA Growth Historical Data

The historical data trend for PURE Bioscience's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PURE Bioscience YoY EBITDA Growth Chart

PURE Bioscience Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.92 102.30 -1,350.00 -48.00 8.11

PURE Bioscience Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.57 - 30.77 33.33 11.11

PURE Bioscience YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PURE Bioscience's YoY EBITDA Growth for the fiscal year that ended in Jul. 2023 is calculated as:

YoY EBITDA Growth (A: Jul. 2023 )
=(EBITDA per Share (A: Jul. 2023 )-EBITDA per Share (A: Jul. 2022 ))/ | EBITDA per Share (A: Jul. 2022 ) |
=(-0.034--0.037)/ | -0.037 |
=8.11 %

PURE Bioscience's YoY EBITDA Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EBITDA Growth (Q: Jan. 2024 )
=(EBITDA per Share (Q: Jan. 2024 )-EBITDA per Share (Q: Jan. 2023 )) / | EBITDA per Share (Q: Jan. 2023 )) |
=(-0.008--0.009)/ | -0.009 |
=11.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PURE Bioscience YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PURE Bioscience's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

PURE Bioscience (PURE Bioscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » PURE Bioscience Inc (OTCPK:PURE) » Definitions » YoY EBITDA Growth
Comparable Companies
SLGD SNBH MNKA BRSH CAWW TANH SKVI BMXC NASO PGID PG XPAR:OR LSE:ULVR CL BOM:500696 EL KMB KVUE LSE:RKT XTER:BEI
Traded in Other Exchanges
N/A
Address
771 Jamacha Road, No. 512, El Cajon, CA, USA, 92019
Website
https://www.purebio.com
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use.
Executives
Robert F Bartlett director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Bernard Blotner director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Tom Y Lee director 1807 SAN GABRIEL BLVD., SAN GABRIEL CA 91776
David Rendall director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Kristin Taylor director 13500 EVENING CREEK DRIVE N, SUITE 550, SAN DIEGO CA 92128
Dale Okuno director 35 N. ARROYO PARKWAY, SUITE 1, PASADENA CA 91103
Ivan Chen director 1725 GILLESPIE WAY, EL CAJON CA 92020
Thomas Richard Myers officer: Chief Operating Officer 1725 GILLESPIE WAY, EL CAJON CA 92130
Henry R. Lambert director, officer: Chief Executive Officer 1725 GILLESPIE WAY, EL CAJON CA 92020
Elisabeth Hagen director 1725 GILLESPIE WAY, EL CAJON CA 92020
Janet Risi Field director 9200 SOUTH DADELAND BOULEVARD, SUITE 800, MIAMI FL 33156
Franchise Brands, Llc 10 percent owner 325 BIC DRIVE, MILFORD CT 06461
Mark Stuart Elliott officer: Vice President, Finance 1725 GILLESPIE WAY, EL CAJON CA 92020
William Otis director 1725 GILLESPIE WAY, EL CAJON CA 92020
David M Theno director 1725 GILLESPIE WAY, EL CAJON CA 92020